Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_assertion type Assertion NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_head.
- NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_assertion description "[Offspring with these high risk IDDM1 genotypes plus the INS VNTR class I/I genotype (n=71; 6.3%) had the highest risk of developing islet autoantibodies (21.8% by age 2 years vs 8.9% in offspring with high risk IDDM1 plus INS VNTR class I/III or III/III genotypes, p<0.05) and T1D (8.5% by age 6 years vs 4.3%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_provenance.
- NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_assertion evidence source_evidence_literature NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_provenance.
- NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_assertion SIO_000772 12750767 NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_provenance.
- NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_assertion wasDerivedFrom befree-20150227 NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_provenance.
- NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_assertion wasGeneratedBy ECO_0000203 NP943202.RAfph-hOgXxVUauPFAMf9NM5OblphT3b7sVjtsJqd8Lao130_provenance.